NASDAQ: GLSI
Greenwich Lifesciences Inc Stock Ownership - Who owns Greenwich Lifesciences?

Insider buying vs selling

Have Greenwich Lifesciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Snehal PatelCEO;CFO2026-07-29700$13.10
$9.17kBuy
Snehal PatelCEO;CFO2026-07-281,500$13.59
$20.39kBuy
Snehal PatelCEO;CFO2026-07-271,500$13.62
$20.43kBuy
Snehal PatelCEO;CFO2026-07-241,100$12.88
$14.17kBuy
Snehal PatelCEO;CFO2026-07-232,500$13.14
$32.85kBuy
Snehal PatelCEO and CFO2026-01-131,800$29.83
$53.69kBuy
Snehal PatelCEO and CFO2026-01-122,900$27.54
$79.87kBuy
Snehal PatelCEO and CFO2025-12-314,300$21.36
$91.85kBuy
Snehal PatelCEO and CFO2025-12-302,900$21.73
$63.02kBuy
Snehal PatelCEO and CFO2025-12-184,100$12.62
$51.74kBuy

1 of 2

GLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GLSI insiders and whales buy or sell their stock.

GLSI Shareholders

What type of owners hold Greenwich Lifesciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Snehal Patel65.77%9,653,878$138.63MInsider
Kinnary Patel9.06%1,329,590$19.09MInsider
Kenneth Hallock5.41%794,308$11.41MInsider
David McWilliams4.23%620,301$8.91MInsider
Blackrock Inc2.96%433,860$6.23MInstitution
Eric Rothe2.13%313,226$4.50MInsider
Vanguard Capital Management LLC2.03%298,266$4.28MInstitution
Jaye Thompson1.80%264,148$3.79MInsider
Geode Capital Management LLC1.06%155,466$2.23MInstitution
State Street Corp0.91%133,875$1.92MInstitution

1 of 3

GLSI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLSI11.59%88.41%Net BuyingNet Buying
ARCT85.46%12.98%Net Buying
RNA86.64%4.28%
MSLE38.33%0.00%
ANTX49.55%50.45%Net SellingNet Selling

Greenwich Lifesciences Stock Ownership FAQ

Who owns Greenwich Lifesciences?

Greenwich Lifesciences (NASDAQ: GLSI) is owned by 11.67% institutional shareholders, 89.01% Greenwich Lifesciences insiders, and 0.00% retail investors. Snehal Patel is the largest individual Greenwich Lifesciences shareholder, owning 9.65M shares representing 65.77% of the company. Snehal Patel's Greenwich Lifesciences shares are currently valued at $138.63M.

If you're new to stock investing, here's how to buy Greenwich Lifesciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.